Active ingredientEnavogliflozinCat. No. P-E044-001CAS 1415472-28-4Family · Pharmaceutical analytical standards
Enavogliflozin
A selective SGLT2 co-transporter inhibitor (gliflozin) for type 2 diabetes, approved in South Korea and Ecuador: it helps remove part of the excess blood sugar through the urine. This family brings together the active ingredient.
Did you know?It has not been studied only in people: a 2022 study assessed its safety and anti-obesity effect in naturally obese dogs.
Go to the active ingredient →Active ingredientEnavogliflozinCat. No. P-E044-001CAS 1415472-28-4No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.